Companies: 10,795·Total market cap: $144.5T
Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc.

BOLTNASDAQHealthcare● Active
$4.66
+$0.10(+2.19%)
Market Cap$8954502
P/E Ratio
52W High$7.35
52W Low$3.91
Overview

Bolt Biotherapeutics, Inc. (BOLT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BOLT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-15.89bolt eps ttm · bolt earnings per shareEarnings history
PE Ratio (TTM)bolt pe ratio ttm · bolt price to earningsPE Ratio deep dive
Revenue (TTM)$6.5Mbolt revenue ttm · bolt annual revenueFull revenue history
Dividend Yield0.06%does bolt pay dividends · bolt dividend yieldDividend history
Shares Outstanding1.9Mbolt shares outstanding · bolt floatShares outstanding history
Next EarningsAug 13, 2026Est.bolt earnings date · bolt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$7.7M▲ +0.07% YoY
202320242025
bolt biotherapeutics, inc. revenue · bolt revenue 2025
FY 2025Net Income-$33.4M▲ +47.12% YoY
202320242025
bolt biotherapeutics, inc. net income · bolt profit 2025
FY 2025EPS$-17.85▼ 981.82% YoY
202320242025
bolt eps · bolt biotherapeutics, inc. earnings per share 2025
TTM:Revenue: $6.5MNet Income: -$29.6MEPS: $-15.89View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold8 analystsis bolt a buy · bolt analyst rating
Strong Buy
0
Buy
3
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$1.00Low
$4.66Current
$4.00Avg Target14.16% downside
$7.00High
bolt price target · bolt 12 month forecast

Total: 8 · Buy rate: 37.5%

The BOLT analyst consensus is Hold, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $4.00, representing -14.16% downside from the current price of $4.66.

Stock Performance

Full History
1D+2.19%
1W-9.86%
1M-0.21%
3M+8.37%
YTD-14.81%
1Y-24.10%
5Y-98.55%

About Bolt Biotherapeutics, Inc.

CEOWilliam Quinn
IPO DateFeb 5, 2021
Employees52
CountryUS

Bolt Biotherapeutics, Inc. a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is deve…

what is bolt biotherapeutics, inc. · bolt stock overview · bolt biotherapeutics, inc. company profile · who is bolt biotherapeutics, inc. ceo · bolt NASDAQ · bolt biotherapeutics, inc. headquarters · bolt biotherapeutics, inc. business segments

About Stock Overview & Key Data

Bolt Biotherapeutics, Inc. (BOLT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 5, 2021. As of the latest trading session, BOLT stock price is $4.66, with a market capitalization of $9.0M. The stock has returned -24.10% over the past 12 months and -14.81% year-to-date.

According to 8 Wall Street analysts, the consensus rating for Bolt Biotherapeutics, Inc. stock is Hold, with an average 12-month price target of $4.00. In fiscal year 2025, Bolt Biotherapeutics, Inc. reported revenue of $7.7M and net income of -$33.4M. For detailed data — including Bolt Biotherapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Bolt Biotherapeutics, Inc. (BOLT) stock price is $4.66. The stock is traded on NASDAQ under the ticker symbol BOLT. The 52-week range is $3.91 – $7.35.

BOLT stock priceBOLT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice